Stuart Kauffman, MD
Kauffman graduated from Dartmouth in 1960, was awarded the BA (Hons) by Oxford University (where he was a Marshall Scholar) in 1963, and completed a medical degree (M.D.) at the University of California, San Francisco in 1968. After completing his residency in Emergency Medicine, he moved into developmental genetics of the fruitfly, holding appointments first at the University of Chicago, then at the University of Pennsylvania from 1975 to 1995, where he rose to Professor of Biochemistry and Biophysics. Kauffman held a MacArthur Fellowship, 1987–1992.
Kauffman rose to prominence through his association with the Santa Fe Institute (a nonprofit research institute dedicated to the study of complex systems), where he was faculty in residence from 1986 to 1997, and through his work on models in various areas of biology. These included autocatalytic sets in origin of life research, gene regulatory networks in developmental biology, and fitness landscapes in evolutionary biology. Kauffman holds the founding broad biotechnology patents in combinatorial chemistry and applied molecular evolution.
In 1996, Kauffman started BiosGroup, a Santa Fe, New Mexico based for-profit company that applied complex systems methodology to business problems. BiosGroup was acquired by NuTech Solutions in early 2003. NuTech was bought by Netezza in 2008.
From 2004 to 2009 Kauffman held a joint appointment at the University of Calgary in Biological Sciences and Physics and Astronomy. He is also an Adjunct Professor in the Department of Philosophy at the University of Calgary. He is an iCORE (Informatics Research Circle of Excellence) chair and the director of the Institute for Biocomplexity and Informatics.
In January 2009 Kauffman became a Finland Distinguished Professor (FiDiPro) at Tampere University of Technology, Department of Signal Processing. The appointment is until the end of 2012. The subject of the FiDiPro research project is the development of delayed stochastic models of genetic regulatory networks based on gene expression data at the single molecule level.
In January 2010 Kauffman joined the University of Vermont faculty where he will continue his work with UVM's Complex Systems Center. He is also an adviser to the Microbes Mind Forum.
Kauffman is a MacArthur Fellow and a Trotter Prize winner, Kauffman has published four major books, among them is At Home in the Universe: The Search for the Laws of Self Organization and Complexity (1995).
Stuart Kauffman is currently working at Institute of Systems Biology.
Leroy Hood, MD, PhD
Dr. Leroy Hood is a world renowned scientist, inventor, entrepreneur and visionary. His discoveries have permanently changed the course of biology, and revolutionized the understanding of genetics, life, and human health. The inventions developed under his leadership include the automated DNA sequencer and an automated tool for synthesizing DNA. He opened the door to the era of big data in medicine.
Hood created the technological foundation for the sciences of genomics (study of genes) and proteomics (study of proteins) through the invention of five groundbreaking instruments and by explicating the potentialities of genome and proteome research into the future through his pioneering of the fields of systems biology and systems medicine. Hood's instruments not only pioneered the deciphering of biological information, but also introduced the concept of high throughput data accumulation through automation and parallelization of the protein and DNA chemistries.
Hood is one of only 15 members of all three United States National Academies, the National Academy of Engineering, the National Academy of Sciences, and the Institute of Medicine. Lee Hood serves as Chairman of the P4 Medicine Institute and as President of the Institute for Systems Biology.
Colin Hill co-founded GNS Healthcare in 2000 and has served as CEO since then. He brings years of hands-on scientific experience to his role, with expertise in the areas of computational physics, artificial intelligence, and personalized medicine. He serves as Chairman of Via Science, a leading big data analytics company focused on the Internet of Things, business intelligence, and finance . He was also a founding member of the Board of Directors of AesRx, a biopharmaceutical company dedicated to the development of new treatment for sickle cell disease (acquired by Baxter in 2014). Colin was the founding chairman of O'Reilly Media's Strata Rx, the first healthcare big data conference.
In 2004, Colin was named to MIT Technology Review's TR100 list of the top innovators in the world under the age of 35. He is a frequent speaker at national and international scientific and industry conferences and has been quoted in in numerous publications and television programs, including The Wall Street Journal, CNBC Morning Call, Nature, Forbes, Wired, and The Economist. He graduated from Virginia Tech with a degree in physics and earned masters degrees in physics from both McGill University and Cornell University.
Kathleen O'Connell is an Edward R. Murrow, Peabody, Alfred I. Dupont and Emmy award winning network television news producer specializing in social issues and content development. She is an experienced longform documentary and newsmagazine producer. Kathleen coordinated and developed visual content for A World Free From Cancer initiative and Value of Medical Innovation. Kathleen is a leading advocate for families navigating the complicated and often perilous journey of a terminally ill diagnosis of a child. She counsels families with brain cancer diagnosis for Imerman Angels, executive produced 35th anniversary film for Friends of Karen, a non profit cancer advocacy organization. Kathleen lives in Sleepy Hollow, NY, and is the mother of 2 children.
Her 14 year old son, Lucas, died in 2010 from a rare, inoperable, brain tumor. Her interaction with the health care system inspired her to advocate for faster access to experimental drugs for terminally ill patients.
The Power Of Mother Love